Literature DB >> 23318599

Endoplasmic reticulum stress with low-dose cyclosporine in frequently relapsing nephrotic syndrome.

Taketsugu Hama1, Koichi Nakanishi, Hironobu Mukaiyama, Yuko Shima, Hiroko Togawa, Mayumi Sako, Kandai Nozu, Kazumoto Iijima, Norishige Yoshikawa.   

Abstract

BACKGROUND: A possible mechanism of cyclosporine (CsA) nephrotoxicity is tubular apoptosis. Endoplasmic reticulum (ER) stress has been shown to be an apoptosis activator. Glucose-regulated proteins 78 and 94 (GRP78, GRP94, respectively) are ER stress-induced chaperones. Eukaryotic translation initiation factor 2α (EIF2α) attenuates protein synthesis. If stress is prolonged, cells undergo apoptosis, inducing the production of GADD153, a transcription factor, which in turn downregulates anti-apoptotic protein B-cell lymphoma 2 (Bcl-2).
METHODS: Endoplasmic reticulum stress-related molecules were evaluated by real-time polymerase chain reaction (PCR) using renal biopsy tissues from 17 children with frequently relapsing nephrotic syndrome before and after 2 years of CsA therapy.
RESULTS: GRP78, GRP94, eIF2α, and Bcl-2 were significantly upregulated in renal biopsy tissues from children 2 years post-CsA treatment. However, there was almost no change in GADD153. Mean ratios of post- to pre-CsA expression of GRP78, GRP94, eIF2α and Bcl-2 were 2.53, 1.80, 2.38 and 1.92, respectively. Post-CsA administration, GRP78 and eIF2α were upregulated by up to sixfold, and GRP94 and Bcl-2 were upregulated by up to fourfold compared with the respective pre-CsA levels. There were significant correlations between GRP78, GRP94, eIF2α, and Bcl-2 levels. These findings suggest that CsA induced an unfolded protein response due to ER stress, but did not cause apoptosis.
CONCLUSIONS: An unfolded protein response due to ER stress induced by CsA may function in a defensive manner, with less apoptosis occurring under low-dose conditions. This finding is important for the rationale for CsA administration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23318599     DOI: 10.1007/s00467-012-2403-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  23 in total

1.  Translational control is required for the unfolded protein response and in vivo glucose homeostasis.

Authors:  D Scheuner; B Song; E McEwen; C Liu; R Laybutt; P Gillespie; T Saunders; S Bonner-Weir; R J Kaufman
Journal:  Mol Cell       Date:  2001-06       Impact factor: 17.970

Review 2.  Patient management by Neoral C(2) monitoring: an international consensus statement.

Authors:  Gary Levy; Eric Thervet; John Lake; Kazuharu Uchida
Journal:  Transplantation       Date:  2002-05-15       Impact factor: 4.939

3.  Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta.

Authors:  T Nakagawa; H Zhu; N Morishima; E Li; J Xu; B A Yankner; J Yuan
Journal:  Nature       Date:  2000-01-06       Impact factor: 49.962

4.  Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis.

Authors:  M J Gregory; W E Smoyer; A Sedman; D B Kershaw; R P Valentini; K Johnson; T E Bunchman
Journal:  J Am Soc Nephrol       Date:  1996-04       Impact factor: 10.121

5.  Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state.

Authors:  K D McCullough; J L Martindale; L O Klotz; T Y Aw; N J Holbrook
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

6.  Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway.

Authors:  S Oyadomari; K Takeda; M Takiguchi; T Gotoh; M Matsumoto; I Wada; S Akira; E Araki; M Mori
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

7.  Early identification of frequent relapsers among children with minimal change nephrotic syndrome. A report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  J Pediatr       Date:  1982-10       Impact factor: 4.406

8.  Suppression of NF-kappaB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response.

Authors:  Shuqi Du; Nobuhiko Hiramatsu; Kunihiro Hayakawa; Ayumi Kasai; Maro Okamura; Tao Huang; Jian Yao; Masayuki Takeda; Isao Araki; Norifumi Sawada; Adrienne W Paton; James C Paton; Masanori Kitamura
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

9.  Intracellular mechanisms of cyclosporin A-induced tubular cell apoptosis.

Authors:  Pilar Justo; Corina Lorz; Ana Sanz; Jesus Egido; Alberto Ortiz
Journal:  J Am Soc Nephrol       Date:  2003-12       Impact factor: 10.121

10.  The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

Authors:  Christian Faul; Mary Donnelly; Sandra Merscher-Gomez; Yoon Hee Chang; Stefan Franz; Jacqueline Delfgaauw; Jer-Ming Chang; Hoon Young Choi; Kirk N Campbell; Kwanghee Kim; Jochen Reiser; Peter Mundel
Journal:  Nat Med       Date:  2008-09       Impact factor: 53.440

View more
  4 in total

1.  Cyclosporine-A induces endoplasmic reticulum stress and influences pro-apoptotic factors in human gingival fibroblasts.

Authors:  Suresh Ranga Rao; Shiyamali Sundararajan; Rajasekaran Subbarayan; Dinesh Murugan Girija
Journal:  Mol Cell Biochem       Date:  2017-03-21       Impact factor: 3.396

2.  Cyclosporin A but not FK506 activates the integrated stress response in human cells.

Authors:  Anthony O Fedele; Valérie Carraro; Jianling Xie; Julien Averous; Christopher G Proud
Journal:  J Biol Chem       Date:  2020-08-24       Impact factor: 5.157

Review 3.  Role of endoplasmic reticulum stress in drug-induced toxicity.

Authors:  Fabienne Foufelle; Bernard Fromenty
Journal:  Pharmacol Res Perspect       Date:  2016-02-04

4.  The molecular chaperone GRP170 protects against ER stress and acute kidney injury in mice.

Authors:  Aidan W Porter; Diep N Nguyen; Dennis R Clayton; Wily G Ruiz; Stephanie M Mutchler; Evan C Ray; Allison L Marciszyn; Lubika J Nkashama; Arohan R Subramanya; Sebastien Gingras; Thomas R Kleyman; Gerard Apodaca; Linda M Hendershot; Jeffrey L Brodsky; Teresa M Buck
Journal:  JCI Insight       Date:  2022-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.